STOCK TITAN

MGX - MGX STOCK NEWS

Welcome to our dedicated news page for MGX (Ticker: MGX), a resource for investors and traders seeking the latest updates and insights on MGX.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect MGX's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of MGX's position in the market.

Rhea-AI Summary
Metagenomi, Inc. (Nasdaq: MGX) successfully closed its initial public offering, raising approximately $93.75 million through the sale of 6,250,000 common shares at $15.00 per share. The underwriters have the option to purchase an additional 937,500 shares at the same price. The company's shares started trading on the Nasdaq Global Select Market under the ticker symbol 'MGX' on February 9, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.79%
Tags
IPO offering
-
Rhea-AI Summary
Metagenomi, Inc. (Nasdaq: MGX) has announced the pricing of its initial public offering of 6,250,000 shares of its common stock at a price to the public of $15.00 per share. The gross proceeds to Metagenomi from the offering are expected to be $93,750,000. The company has also granted the underwriters a 30-day option to buy an additional 937,500 shares of its common stock at the initial public offering price. The shares are expected to begin trading on the Nasdaq Global Select Market on February 9, 2024 under the ticker symbol MGX. The offering is expected to close on February 13, 2024. J.P. Morgan, Jefferies, TD Cowen, Wells Fargo Securities, and BMO Capital Markets are acting as joint book-running managers, with Chardan as the lead manager for the offering.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
IPO offering
MGX

Nasdaq:MGX

MGX Rankings

MGX Stock Data